Poland
Labplus, founded in 2018 and headquartered in Poland, is revolutionizing patient care by turning complex laboratory results into actionable health insights. Their slogan, "Transforming laboratory results into personalized health guidance for patients," captures their mission to simplify and enhance healthcare interactions.
Specializing in AI, Health Care, and Medical Devices, Labplus has developed the world's first clinically validated device that offers interpretations of lab results, fostering ongoing patient relationships. This innovation has enabled them to deliver over 1 million interpretations and secure partnerships with 50% of Poland's lab market. The company is currently expanding across Europe, setting a new standard in healthcare.
Backed by investors Movens Capital and LT Capital, Labplus secured a PLN7.00M Pre Seed Round in December 2021. Their robust compliance with EU regulations, including EU MDR certification and GDPR compliance, further strengthens their position in the industry.
